Defensins: antifungal lessons from eukaryotes
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Over the last years, antimicrobial peptides (AMPs) have been the focus of intense research toward the finding of a viable alternative to current antifungal drugs. Defensins are one of the major families of AMPs and the most represented among all eukaryotic groups, providing an important first line of host defense against pathogenic microorganisms. Several of these cysteine-stabilized peptides present a relevant effect against fungi. Defensins are the AMPs with the broader distribution across all eukaryotic kingdoms, namely, Fungi, Plantae, and Animalia, and were recently shown to have an ancestor in a bacterial organism. As a part of the host defense, defensins act as an important vehicle of information between innate and adaptive immune system and have a role in immunomodulation. This multidimensionality represents a powerful host shield, hard for microorganisms to overcome using single approach resistance strategies. Pathogenic fungi resistance to conventional antimycotic drugs is becoming a major problem. Defensins, as other AMPs, have shown to be an effective alternative to the current antimycotic therapies, demonstrating potential as novel therapeutic agents or drug leads. In this review, we summarize the current knowledge on some eukaryotic defensins with antifungal action. An overview of the main targets in the fungal cell and the mechanism of action of these AMPs (namely, the selectivity for some fungal membrane components) are presented. Additionally, recent works on antifungal defensins structure, activity, and cytotoxicity are also reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457 · cited 3×
“REVIEW ARTICLE published: 20 March 2014 doi: 10.3389/fmicb.2014.00097 Defensins: antifungal lessons from eukaryotes”
BackgroundInfluentialEmerging fungal threats to animal, plant and ecosystem health
Fisher, M. C., Henk, D. A., Briggs, C. J., Brownstein, J. S., Madoff, L. C., McCraw, S. L., & Gurr, S. J. (2012) · Nature · doi:10.1038/nature10947 · Cited by 3,310 · cited 2×
“REVIEW ARTICLE published: 20 March 2014 doi: 10.3389/fmicb.2014.00097 Defensins: antifungal lessons from eukaryotes”
BackgroundInfluentialPlasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.-H., Homey, B., Cao, W., Wang, Y.-H., Su, B., Nestle, F. O., et al. (2007) · Nature · doi:10.1038/nature06116 · Cited by 1,910 · cited 1×
“Surprisingly, some defensins are also able to attenuate proinflammatory responses whenever these can be harmful to the organism (Lande et al., 2007; Yamasaki et al., 2007).”
BackgroundCandida albicans pathogenicity mechanisms
Mayer, F. L., Wilson, D., & Hube, B. (2013) · Virulence · doi:10.4161/viru.22913 · Cited by 1,848 · cited 1×
“For this reason, plants need to have good defenses against these microorganisms; thus, it is easy conceivable that plants are major AMPs producers, often with antifungal activity, but also antibacterial activity (Moreno et al., 1994; Segura et al., 1998; Thomma et al., 2002; Mayer et al., 2013).”
Backgroundβ-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6
Yang, D., Chertov, O., Bykovskaia, S. N., Chen, Q., Buffo, M. J., Shogan, J., Anderson, M., Schröder, J. M., Wang, J. M., Howard, O. M. Z., et al. (1999) · Science · doi:10.1126/science.286.5439.525 · Cited by 1,809 · cited 1×
“…and Dorin, 2012; Ulm et al., 2012; Zhu and Gao, 2013). β-Defensins were demonstrated to have the capability to induce chemoattraction of CD4+ memory T cells, macrophages, and immature dendritic cells, by binding to receptors in the membrane (Yang et al., 1999; Wu et al., 2003; Taylor et al., 2008).”
BackgroundMammalian defensins in immunity: more than just microbicidal
Yang, D., Biragyn, A., Kwak, L. W., & Oppenheim, J. J. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02246-9 · Cited by 696
Noble, S. M., French, S., Kohn, L. A., Chen, V., & Johnson, A. D. (2010) · Nature Genetics · doi:10.1038/ng.605 · Cited by 678
Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection
Gläser, R., Harder, J., Lange, H., Bartels, J., Christophers, E., & Schröder, J.-M. (2005) · Nature Immunology · doi:10.1038/ni1142 · Cited by 651 · cited 2×
“REVIEW ARTICLE published: 20 March 2014 doi: 10.3389/fmicb.2014.00097 Defensins: antifungal lessons from eukaryotes”
BackgroundInfluentialWang, D. Y.-C., Kumar, S., & Hedges, S. B. (1999) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.1999.0617 · Cited by 493 · cited 1×
“…Dierckx (Seibold et al., 2011), is important to demonstrate the wide distribution of these peptides over diverse eukaryotic lineages, which suggests that ancestral defensin genes existed over 1500 million years ago, before Fungi, Plantae, and Animalia kingdoms diverged (Wang et al., 1999).”
BackgroundRegulation of Cell-Surface Genes and Biofilm Formation by the C. albicans Transcription Factor Bcr1p
Nobile, C. J., & Mitchell, A. P. (2005) · Current Biology · doi:10.1016/j.cub.2005.05.047 · Cited by 464 · cited 1×
“…Resistance and Chemotherapy March 2014 | Volume 5 | Article 97 | 8 Candida albicans resistance to some AMPs is regulated by the protein Ssd1, combined with the transcription factor Bcr1 (biofilm and cell wall regulator; Nobile and Mitchell, 2005; Gank et al., 2008; Jung et al., 2013).”
BackgroundThe natural history of antibiotics
Clardy, J., Fischbach, M. A., & Currie, C. R. (2009) · Current Biology · doi:10.1016/j.cub.2009.04.001 · Cited by 402 · cited 2×
“These antibiotics are losing efficacy as a result of high selection pressure, leading to rapid emergence of resistance in many important human pathogens, thus threatening to put an end to the golden age of antibiotics (Clardy et al., 2009; Fisher et al., 2012).”
BackgroundEnjalbert, B., Smith, D. A., Cornell, M. J., Alam, I., Nicholls, S., Brown, A. J. P., & Quinn, J. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-06-0501 · Cited by 381
Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans
Rittershaus, P. C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27890 · Cited by 239
Sagaram, U. S., Pandurangi, R., Kaur, J., Smith, T. J., & Shah, D. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018550 · Cited by 185 · cited 1×
“…references: Medicago sativa defensin 1 (MsDef1) and Medicago truncatula defensin 4 (MtDef4; Spelbrink et al., 2004; Ramamoorthy et al., 2007a,b; Sagaram et al., 2011); Dahlia merckii AMP 1 (DmAMP1; Thevissen et al., 1999, 2000a,b, 2003b; Jha et al., 2009; Salahinejad et al., 2013); Phaseolus…”
BackgroundTsai, P.-W., Yang, C.-Y., Chang, H.-T., & Lan, C.-Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017755 · Cited by 175 · cited 1×
“Cathelicidins are found in the innate immune system of mammals, amphibians, and reptiles (Wang et al., 2008; Tsai et al., 2011; Hao et al., 2012); dermaseptins and magainins are found in amphibians (Morton et al., 2007); cecropins are found in insects (YiZeng et al., 1989); and defensins, which are…”
BackgroundCoprisin-induced antifungal effects in Candida albicans correlate with apoptotic mechanisms
Lee, J., Hwang, J.-S., Hwang, I.-S., Cho, J., Lee, E., Kim, Y., & Lee, D. G. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.03.012 · Cited by 64
Galgóczy, L., Papp, T., Lukács, G., Leiter, Ã., Pócsi, I., & Vágvölgyi, C. (2007) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2007.00661.x · Cited by 37
Cited by
Human Antimicrobial Peptides and Proteins
Wang, G. (2014) · Pharmaceuticals · doi:10.3390/ph7050545 · Cited by 528
Meneguetti, B. T., Machado, L. D. S., Oshiro, K. G. N., Nogueira, M. L., Carvalho, C. M. E., & Franco, O. L. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02136 · Cited by 77
“…medical use is likely to increase as anti-infective and immunomodulatory therapeutics (Matsuzaki, 1999; Mandal et al., 2009; Maróti et al., 2011; Silva et al., 2012, 2014; Jeong et al., 2015; Santana et al., 2015), in intracellular drug delivery, RNA, DNA, and nanoparticles in a non-destructive…”
BackgroundInnate Inspiration: Antifungal Peptides and Other Immunotherapeutics From the Host Immune Response
Mercer, D. K., & O'Neil, D. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02177 · Cited by 50
Garrigues, S., Gandía, M., Borics, A., Marx, F., Manzanares, P., & Marcos, J. F. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00592 · Cited by 32
Nanoparticle decoration impacts airborne fungal pathobiology
Westmeier, D., Solouk-Saran, D., Vallet, C., Siemer, S., Docter, D., Götz, H., Männ, L., Hasenberg, A., Hahlbrock, A., Erler, K., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1804542115 · Cited by 22
“Besides antimycotic drugs, natural antifungal peptides, such as human defensins, have been considered as future therapeutics (14).”
Background
Metadata
- Authors
- Silva, P. M., Gonçalves, S., & Santos, N. C.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2014-03-20
- Volume
- 5
- Pages
- 97-97
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W2027424984
- Cited by
- 125
- References
- 17
- FWCI
- 8.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.